Murray Yule
Plus aucun poste en cours
Provenance du réseau au premier degré de Murray Yule
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Murray Yule via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
| THERACRYF PLC | Medical/Nursing Services | Chairman Director/Board Member | |
| Brown University | College/University | Masters Business Admin | |
NorgesInvestor Formuesforvaltning AS
 NorgesInvestor Formuesforvaltning AS Investment ManagersFinance NorgesInvestor Formuesforvaltning AS is a group of companies that focuses on strategic and financial value development. The private company's investment arm, NorgesInvestor Proto, invests in companies listed on the Oslo Stock Exchange. The company is based in Oslo, Norway. and has subsidiaries in Norway and Sweden. The Norwegian company was founded in 1996 by Jan Gunnar Hartvig, Stein Holst Annexstad. The CEO is Øivind E. Hermansen. | Investment Managers | Founder | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| Oxford Brookes University | College/University | Masters Business Admin | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
| University of Oslo | College/University | Graduate Degree Graduate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Norwegian University of Science & Technology | College/University | Graduate Degree | |
| University of Bergen | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
Ernst & Young AS
 Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kantega AS
 Kantega AS Miscellaneous Commercial ServicesCommercial Services Kantega AS provides IT consulting services. It offers design, development, and the integration of applications for companies that require out sourcing services, as well as consultation and maintenance. The company was founded in 2003 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | President | |
Investinor AS
 Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Investment Managers | Chairman Private Equity Investor | |
REMA 1000 AS
 REMA 1000 AS Food RetailRetail Trade REMA 1000 AS retails grocery products and offers a chain of supermarket. Its office tasks include joint marketing and procurement, finance and information technology, operations, establishing, and central support. The regional offices provides regional marketing and establishes new stores in the area. The company was founded in 1979 and is headquartered in Oslo, Norway. | Food Retail | Director of Finance/CFO | |
| Warszawski Uniwersytet Medyczny | College/University | Doctorate Degree | |
| Baxter Medical AB | Corporate Officer/Principal | ||
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Director/Board Member | |
| University of Kent | College/University | Undergraduate Degree | |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Biotechnology | Founder | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member | |
| COMBIGENE AB | Pharmaceuticals: Major | Director/Board Member | |
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
| West Thorpe (2011) Ltd. | Director/Board Member | ||
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member | |
Delin Ventures Ltd.
 Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Bio-Me AS
 Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
J&J Future Invest AS
 J&J Future Invest AS Real Estate DevelopmentFinance J & J Future Invest AS is a Norwegian company that operates a real estate agency. | Real Estate Development | Corporate Officer/Principal | |
K & K AS
 K & K AS Miscellaneous Commercial ServicesCommercial Services K & K AS manages securities. The company was founded on June 26, 2002 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Tappin AS | Director/Board Member | ||
Oribiotech Ltd.
 Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Investment Officer | |
| Norwegian Cancer Society | Director/Board Member | ||
| ONCOZENGE AB | Pharmaceuticals: Major | Director/Board Member | |
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Norvège | 21 |
| Royaume-Uni | 14 |
| Suède | 7 |
| Etats-Unis | 5 |
| Pays-Bas | 3 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 74 |
| Corporate Officer/Principal | 33 |
| Chairman | 21 |
| Independent Dir/Board Member | 19 |
| Director of Finance/CFO | 11 |
Relations les plus connectées
| Insiders | |
|---|---|
| Susan Foden | 32 |
| Hilde Furberg | 21 |
| Jon-Øyvind Eriksen | 16 |
| Stein Holst Annexstad | 15 |
| David Wilson | 14 |
| Kari Grønås | 12 |
| Marit Austgulen Wick | 10 |
| Alan Barge | 10 |
| Anthony Brown | 10 |
| Stener Kvinnsland | 9 |
| Sergej M. Kiprijanov | 7 |
| Khatereh Ahmadi | 5 |
| Petter Nielsen | 4 |
| Julia Schölermann | 4 |
| Rune Skeie | 4 |
- Bourse
- Insiders
- Murray Yule
- Connexions Sociétés
